AstraZeneca has initiated the global withdrawal of its COVID-19 vaccine, Vaxzevria, citing a surplus of more advanced vaccine options targeting emerging variants of the virus.
Advertisement
AstraZeneca has initiated the global withdrawal of its COVID-19 vaccine, Vaxzevria, citing a surplus of more advanced vaccine options targeting emerging variants of the virus.